Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

DXP Enterprises (NASDAQ:DXPE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 09:00 AM. Here's what investors need to know about the announcement. Earnings DXP Enterprises reported an EPS of $0.65.

Benzinga

Mid-Morning Market Update: Markets Open Higher; Nasdaq Jumps Over 200 Points

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Benzinga

AFC Gamma Touts Strong Performance In Q1, Steady Dividend Growth

AFC Gamma, Inc. (NASDAQ: AFCG) reported its results for the first quarter of 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why RADA Electronic Shares Are Plunging Today

RADA Electronic Industries Ltd (NASDAQ:RADA) reported a first-quarter revenue decline of 11% year-over-year to $22.5 million, missing the consensus of $30.79 million. EPS loss was $(0.01), below the consensus of $0.12. Gross profit declined by 26.3% to $7.34 million, and margin contracted by 690 bps to 32.6%. RADA recorded an operating loss…

Benzinga

Akerna Shares Slightly Down On Q1 Earnings Report, Revenue Improves

Akerna (NASDAQ: KERN) reported its unaudited financial results for the quarter ended March 31, 2022.

Benzinga

PayPal And 3 Other Stocks Insiders Are Selling

Gold futures traded slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Cerence Reports Mixed Q2 Results; Margins Shrink Due To Automotive Headwinds

Cerence Inc (NASDAQ:CRNC) reported a second-quarter FY22 revenue decline of 12.5% year-on-year to $86.3 million, above the consensus of $84.6 million. Non-GAAP EPS of $0.33 missed the consensus of $0.34. Segments: Revenue from License fell 14.8% Y/Y to $46.3 million, Connected services decreased 30.3% Y/Y to $19.3 million, and Professional services rose 24.7% Y/Y…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

3 Stocks Under $5 Insiders Are Aggressively Buying

US crude oil futures traded lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading…

Benzinga

Village Farms' Q1 Consolidated Adjusted EBITDA Falls YoY, Revenue Surpasses $70M

Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) announced its financial results for the first quarter ended March 31, 2022.

Benzinga

Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs

Psychedelics policy action took center stage this week.

Benzinga

Executives Buy Around $141M Of 4 Stocks

Although Dow Jones futures traded higher this morning on Tuesday, there were a few notable insider trades.

Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Turning Point Therapeutics Gets FDA Breakthrough Therapy designation For Repotrectinib

Turning Point Therapeutics, Inc. (NASDAQ: TPTX) received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its lead drug candidate Repotrectinib in Patients With One Prior ROS1 Tyrosine Kinase Inhibitor and no Prior Chemotherapy.

Benzinga

Reading Intl: Q1 Earnings Insights

Reading Intl (NASDAQ:RDI) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings Reading Intl missed estimated earnings by 59.09%, reporting an EPS of $-0.7 versus an estimate of $-0.44.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where BioNTech Stands With Analysts

Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Heska

Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ:HSKA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What 13 Analyst Ratings Have To Say About Upstart Hldgs

Analysts have provided the following ratings for Upstart Hldgs (NASDAQ:UPST) within the last quarter:

Benzinga

Analyst Ratings for Victory Capital Holdings

Victory Capital Holdings (NASDAQ:VCTR) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

How Is The Market Feeling About Tesla?

Tesla's (NASDAQ:TSLA) short percent of float has fallen 3.32% since its last report. The company recently reported that it has 24.55 million shares sold short, which is 2.91% of all regular shares that are available for trading.

Benzinga

Dream Finders Homes: Q1 Earnings Insights

Dream Finders Homes (NASDAQ:DFH) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Achilles Therapeutics: Q1 Earnings Insights

Achilles Therapeutics (NASDAQ:ACHL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Analyst Ratings for CarGurus

Within the last quarter, CarGurus (NASDAQ:CARG) has observed the following analyst ratings:

Benzinga

Expert Ratings for Tesla

Over the past 3 months, 14 analysts have published their opinion on Tesla (NASDAQ:TSLA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Expert Ratings for Viatris

Analysts have provided the following ratings for Viatris (NASDAQ:VTRS) within the last quarter:

Benzinga

Recap: Aclaris Therapeutics Q1 Earnings

Aclaris Therapeutics (NASDAQ:ACRS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

1 … 519 520 521 522

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.